Checkpoint Therapeutics, Inc. (CKPT): Price and Financial Metrics
Checkpoint Therapeutics, Inc. (CKPT)
Today's Latest Price: $2.22 USD
0.02 (0.91%)
Updated Feb 18 8:00pm
Add CKPT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
CKPT Stock Summary
- The ratio of debt to operating expenses for Checkpoint Therapeutics Inc is higher than it is for about only 0.37% of US stocks.
- Revenue growth over the past 12 months for Checkpoint Therapeutics Inc comes in at 484.14%, a number that bests 98.49% of the US stocks we're tracking.
- The volatility of Checkpoint Therapeutics Inc's share price is greater than that of 93.14% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to Checkpoint Therapeutics Inc are SPRO, PLX, AFMD, VYGR, and MRSN.
- Visit CKPT's SEC page to see the company's official filings. To visit the company's web site, go to www.checkpointtx.com.
CKPT Daily Price Range
CKPT 52-Week Price Range
CKPT Stock Price Chart More Charts
CKPT Price/Volume Stats
| Current price | $2.22 | 52-week high | $5.20 |
| Prev. close | $2.20 | 52-week low | $1.12 |
| Day low | $2.16 | Volume | 115,000 |
| Day high | $2.30 | Avg. volume | 231,488 |
| 50-day MA | $1.66 | Dividend yield | N/A |
| 200-day MA | $2.56 | Market Cap | 84.85M |
Checkpoint Therapeutics, Inc. (CKPT) Company Bio
Checkpoint Therapeutics, Inc., an immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of non-chemotherapy and immune-enhanced combination treatments for patients with solid tumor cancers. The company was founded in 2014 and is based in New York, New York. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.
Top Stories View All
Best & Worst Performing Stock Industries for February 18, 2020
Best & Worst Performing Small Cap Stocks for February 18, 2020
Best & Worst Performing Mid Cap Stocks for February 18, 2020
Best & Worst Performing Large Cap Stocks for February 18, 2020
Best & Worst Performing Mega Cap Stocks for February 18, 2020
View All Top Stories
Loading social stream, please wait...